Dec 15 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* Press release - Valeant announces new U.S. fulfillment agreements with
Walgreens; plans to further extend distribution to independent pharmacies
* To reduce prices by 10 percent for all dermatological,ophthalmological
products distributed through more than 8,000 Walgreens retail outlets
* Pharma- to reduce prices by 10 percent for all dermatological and
ophthalmological products distributed through Walgreens retail outlets
* Estimates price decreases across both programs expected to provide healthcare
system up to $600 million in annual savings
* To also distribute certain branded products through Walgreens at generic
prices
* Reduced pricing will apply to wholesale list prices of products and will be
phased in over next 6-9 months
* Says agreement also covers valeant's over-the-counter product portfolio
* Co, Walgreens also entered into separate agreement under which Valeant will
distribute more than 30 branded products
* Source text for Eikon ID:nCNWtTZcta
* Further company coverage VRX.TO